Novavax, Inc. (“Novavax”) announced that FDA approved its Biologics License Application (“BLA”) for Nuvaxovid™ for active ...

The framework the new FDA leaders laid out on Tuesday raised small and big questions about the regulatory process, vaccine ...

The FDA's Vaccines and Related Biological Products Advisory Committee was scheduled for next month. But the agency notified committee members that the meeting had been canceled. The Food and Drug ...

The vaccine advisory committee for the Food and Drug Administration met Thursday to discuss potential changes to the formula ...

"A planned March 13 meeting of the FDA’s Vaccines and Related Biological Products Advisory Committee on the influenza vaccine strains for the 2025-2026 influenza season in the northern ...

The FDA's Advisory Committee calendar, updated as of Wednesday, shows no March meetings scheduled. As for the VRBPAC specifically, its "meeting materials" archive shows no content for the current ...

The company said the FDA is considering holding an advisory committee meeting, though the agency provided no official date. Capricor CEO Linda Marbán said the company has been “actively ...

The FDA has approved Novavax’s protein-based COVID-19 vaccine, giving some Americans another option besides messenger RNA ...